Targa Biomedical
PrivateLast Round
Accelerator
Dec 10, 2020
Company Overview
Targa Biomedical operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was an Accelerator round in December 2020.
Targa Biomedical is a biotechnology company developing pharmacological assets to optimize the manufacturing quality and clinical impact of cell therapy and increase opportunities for organ transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Targa Biomedical Comparables
Compare Targa Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hemarina | 75% | |
| Carnamedica Sp. z o.o. | 72% | |
| Accord Healthcare | 71% |
For institutional investors. Book with your work email.
Targa Biomedical Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Targa Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gouvernement du Québec | Accelerator |
| adMare BioInnovations | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 2473% MoM, from 15 to 386.
- Apr 6, 2026
Monthly visitors increased 3413% from 15 to 527.
For institutional investors. Book with your work email.
Targa Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Targa Biomedical's valuation, stock price, and market status.
Is Targa Biomedical a public or private company?
Targa Biomedical is a private company.
What is the current stock price of Targa Biomedical?
Targa Biomedical is a private company, so its shares have no public market price. Caplight tracks Targa Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Targa Biomedical worth (valuation)?
Valuation information for Targa Biomedical is not publicly available.
Can I buy Targa Biomedical stock?
Targa Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Targa Biomedical's last funding round?
Targa Biomedical's most recent funding round was Accelerator on December 10, 2020.
Who are the main investors in Targa Biomedical?
Key investors in Targa Biomedical include Gouvernement du Québec, adMare BioInnovations.
Will Targa Biomedical IPO soon?
No public IPO plans have been announced for Targa Biomedical.
How can I track Targa Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in Targa Biomedical's shares on secondary markets.